The recession triggered by Covid-19 has been unusual in many ways. For investors, perhaps the most striking feature of this recession has been the degree to which it has created winners and losers.
The technology stocks that have provided the hardware and software to enable vast swathes of the population to work and shop from home have been key beneficiaries. In contrast, many companies and sectors that rely on people going out continue to languish. But which stocks still offer value and could benefit if a Covid-19 vaccine becomes viable and life is able to return to that which we once knew? Of course, we do not know when, or even if, a vaccine will become available, so the following opportunities seem most suitable for those investors with longer horizons. US value stocks Wh...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes